98 related articles for article (PubMed ID: 16168529)
1. Evidence for adjuvanticity of anthrax edema toxin.
Quesnel-Hellmann A; Cleret A; Vidal DR; Tournier JN
Vaccine; 2006 Feb; 24(6):699-702. PubMed ID: 16168529
[TBL] [Abstract][Full Text] [Related]
2. Anthrax edema factor potency depends on mode of cell entry.
Hong J; Beeler J; Zhukovskaya NL; He W; Tang WJ; Rosner MR
Biochem Biophys Res Commun; 2005 Sep; 335(3):850-7. PubMed ID: 16099427
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies.
Little SF; Leppla SH; Burnett JW; Friedlander AM
Biochem Biophys Res Commun; 1994 Mar; 199(2):676-82. PubMed ID: 8135809
[TBL] [Abstract][Full Text] [Related]
4. Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen.
Zmuda JF; Zhang L; Richards T; Pham Q; Zukauskas D; Pierre JL; Laird MW; Askins J; Choi GH
J Immunol Methods; 2005 Mar; 298(1-2):47-60. PubMed ID: 15847796
[TBL] [Abstract][Full Text] [Related]
5. [Expression and analysis of biological activity of the recombination anthrax edema factor].
Dong DY; Xu JJ; Song XH; Fu L; Chen W
Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):459-62. PubMed ID: 15989247
[TBL] [Abstract][Full Text] [Related]
6. Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin.
Huber M; Vor Dem Esche U; Grunow R; Bessler WG
Drugs Exp Clin Res; 2005; 31(2):35-43. PubMed ID: 15929604
[TBL] [Abstract][Full Text] [Related]
7. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
8. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109.
Gu M; Hine PM; James Jackson W; Giri L; Nabors GS
Vaccine; 2007 Jan; 25(3):526-34. PubMed ID: 16973247
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
Berthold I; Pombo ML; Wagner L; Arciniega JL
Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
[TBL] [Abstract][Full Text] [Related]
10. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.
Klinman DM; Xie H; Ivins BE
Ann N Y Acad Sci; 2006 Oct; 1082():137-50. PubMed ID: 17145935
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
Sloat BR; Cui Z
J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361
[TBL] [Abstract][Full Text] [Related]
12. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
Sloat BR; Cui Z
Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
[TBL] [Abstract][Full Text] [Related]
13. Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis.
Little SF
Biochem Biophys Res Commun; 2004 Apr; 317(1):294-300. PubMed ID: 15047182
[TBL] [Abstract][Full Text] [Related]
14. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage.
Kuo SR; Willingham MC; Bour SH; Andreas EA; Park SK; Jackson C; Duesbery NS; Leppla SH; Tang WJ; Frankel AE
Microb Pathog; 2008 Jun; 44(6):467-72. PubMed ID: 18222626
[TBL] [Abstract][Full Text] [Related]
15. Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.
Duverger A; Carré JM; Jee J; Leppla SH; Cormet-Boyaka E; Tang WJ; Tomé D; Boyaka PN
J Immunol; 2010 Nov; 185(10):5943-52. PubMed ID: 20952678
[TBL] [Abstract][Full Text] [Related]
16. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
[TBL] [Abstract][Full Text] [Related]
17. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.
Maldonado-Arocho FJ; Fulcher JA; Lee B; Bradley KA
Mol Microbiol; 2006 Jul; 61(2):324-37. PubMed ID: 16856939
[TBL] [Abstract][Full Text] [Related]
18. Femtomolar detection of the anthrax edema factor in human and animal plasma.
Duriez E; Goossens PL; Becher F; Ezan E
Anal Chem; 2009 Jul; 81(14):5935-41. PubMed ID: 19522516
[TBL] [Abstract][Full Text] [Related]
19. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
Sloat BR; Shaker DS; Le UM; Cui Z
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
[TBL] [Abstract][Full Text] [Related]
20. Production of biologically active Bacillus anthracis edema factor in Escherichia coli.
Cooksey BA; Sampey GC; Pierre JL; Zhang X; Karwoski JD; Choi GH; Laird MW
Biotechnol Prog; 2004; 20(6):1651-9. PubMed ID: 15575695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
